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1. Introduction 
In recent years stem cells become a major topic both publicly and scientifically owing to 
their promise to cure diseases and restore organ functionality. Yet our understanding of the 
biology of stem cells and their inherent features is largely lagging behind the great promise 
of using these cells in transplantation therapies. In this chapter we highlight several aspects 
of the biology of stem cells/induced pluripotent stem (iPS) cells that are often overlooked. 
We define stem cells not only by their developmental capacities, namely, self-renewal and 
multi-lineage differentiation, but also by their inherent features. We present new 
bioinformatic data and draw the stem cell picture based on recent knowledge emerging 
from studying stem cells in plant and animal systems with emphasis on chromatin 
structure. We highlight some of the potentially hazardous pathways associated with cellular 
dedifferentiation (iPS cells) and with culturing stem cells. Notably, genomic modification 
associated with iPS cells is often discussed with respect to the methodology of introducing 
reprogramming genes into the host cells, namely, lentiviral/retroviral transduction, while 
ignoring the potential genomic modification naturally associated with dedifferentiation or 
with stress events. Based on our understanding of cellular processes accompanied stress 
response and cellular dedifferentiation we discuss strategies for improving the quantity and 
quality of iPS cells.  
2. Inherent features of stem cells 
2.1 What are stem cells? 
One major, long recognized, pitfall in stem cell biology is that stem cells are commonly 
defined by their developmental potentialities, namely, self-renewal and multitype 
differentiation, rather than by their intrinsic features (Potten & Loeffler, 1990; McKay, 2000). 
This often leads to the erroneous assumption that reentry of stem cells to the cell cycle for 
the purpose of the so-called ‘self-renewal’ represents an inherent feature of stem cells. 
Consequently, the term stem cell culture has been established, leading biologists to 
incorrectly assume that stem cell features can be fully maintained under culture conditions 
(Grafi & Avivi, 2004). Considering that animal somatic cells are capable to become stem cells 
via dedifferentiation (Kurisaki et al., 2010), the traditional developmental capacity-based 
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definition of stem cells may be useless in distinguishing between genuine stem cells and 
somatic cells that have the capacity to become stem cells. Obviously, defining stem cells by 
their inherent features or signature rather than their developmental capabilities is necessary.  
The signature of a given differentiated cell is commonly reflected in its gene expression 
profile. The attempts to uncover the ‘stem cell signature’ or the ‘stemness genes’ via 
transcriptome analysis of different stem cell culture lines were failed as these experiments 
yielded different ‘signatures’ and non-overlapping ‘stemness genes’ (Ramalho-Santos et al., 
2002; Ivanova et al., 2002; Fortunel et al., 2003). This again highlighted the problem of 
defining stem cells by their developmental capacity, namely, self-renewal (cultured cells) 
(Grafi & Avivi, 2004). Contrary to the idea that stem cells represent a unique entity that is 
characterized by the expression of specific set of ‘stemness’ genes, it has been suggested that 
stem cells represent a unique transient state characterized by promiscuous expression of 
marker genes (Zipori, 2004). Consequently, several possibilities could describe the 
transcriptional landscapes of stem cells: (i) differentiation/lineage-specific genes are not 
expressed in stem cells, (ii) differentiation/lineage-specific genes are widely expressed in 
stem cells but at a very low level, and (iii) differentiation/lineage-specific genes are not 
expressed but assume a transcriptionally competent chromatin state (Zipori, 2004; Meshorer 
& Misteli, 2006; Efroni et al., 2008). The later is supported by the fact that stem cells, like 
dedifferentiating cells, acquire open, decondensed chromatin architecture, which is essential 
though not sufficient for initiating gene transcription (Williams et al., 2003; Grafi, 2004; 
Gaspar-Maia et al., 2011) as well as by the finding that some non-expressed genes or genes 
expressed at low levels in embryonic stem (ES) cells are primed but their transcription is 
attenuated by a unique combination of permissive and restrictive chromatin marks (Azuara 
et al., 2006; Bernstein et al., 2006). Apparently open chromatin configuration appears to be 
an intrinsic feature of stem cells that can be used to distinguish between actual stem cells 
and potential stem cells.  
2.2 Chromatin structure and regulation in brief 
The basic structural unit of chromatin is the nucleosome, which is composed of DNA 
wrapped around histone octamer made of two of each of core histone proteins, namely, 
H2A, H2B, H3 and H4. All core histone proteins share a common structural motif called the 
histone fold consisting of three alpha helices connected by short loops (Arents & 
Moudrianakis, 1995). The X-ray crystal structure of the nucleosome core particle showed 
that interactions between core histone proteins or between histone octamer and duplex 
DNA are largely dependent on the histone fold motif. The histone amino-terminal tail is 
unstructured and protruding outside the nucleosomal disk where it can contact with 
neighboring nucleosomes or with proteins or protein complexes that affect chromatin 
structure and function. The structure of chromatin is highly dynamic, facilitating the 
transition between permissive and repressive chromatin. This dynamic structure is 
controlled by multiple types of reversible chemical modifications that occur on the DNA 
(cytosine methylation) or on the DNA interacting core histone proteins. Most modifications 
of histone proteins occur on the N-terminal tails and include acetylation, methylation, 
phosphorylation, and ubiquitination. These chemical modifications can directly affect the 
interaction with DNA or generate binding sites for recruitment of proteins or protein 
complexes that affect the structure and function of chromatin and consequently 
differentiation and development. Gene promoters can be found in three fundamental states 
determined by their histone modification marks, namely, restrictive (e.g., methylated 
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H3K9/K27), permissive (e.g., methylated H3K4, acetylated H3K9) or both restrictive and 
permissive (e.g., methylated H3K27, methylated H3K4, also known as ‘bivalent’ state). For 
example, SET domain-containing histone methyltransferase proteins, such as Clr4 (Cryptic 
locus regulator) in Schizosaccharomyces pombe and SUV39H1 and SUV39H2 in humans are 
enzymes that methylate histone H3 specifically at lysine 9 (Rea et al., 2000). This methylation 
generates a binding site for Heterochromatin protein 1 (HP1) (Bannister et al., 2001; Lachner 
et al., 2001), which is required for the establishment of a condensed, repressive chromatin. 
Conversely, histone acetylation or methylation of histone H3 at lysine 4 are often associated 
with 'open' chromatin configuration and gene transcription (Eberharter & Becker, 2002; Lee 
& Workman, 2007; Eissenberg & Shilatifard, 2010). More recently it has been shown that 
some non-expressed genes or genes expressed at low levels in ES cells carry both permissive 
(H3K4me3; trimethylated H3K4) and restrictive (H3K27me3; trimethylated H3K27) 
chromatin marks (Azuara et al., 2006; Bernstein et al., 2006). This unique ‘bivalent’ 
chromatin state suggests a model in which many tissue-specific regulatory genes are 
‘primed’ but their transcription is delayed until entry into a specific differentiation pathway 
that dictate either activation (e.g., recruitment of H3K27 demethylases) or silencing (e.g., 
recruitment of H3K4 demethylses) of the gene locus (Lan et al., 2008). Notably, bivalent 
domains were found to occur also in the rice genome in somatic cells where a large 
proportion of genes possessing the repressive mark H3K27me3 also contained permissive 
marks of H3K4me3 and H3K9ac (acetylated H3K9) (He et al., 2010).  
2.3 Chromatin modifiers and the establishment of stem cell state 
Stem cells as well as dedifferentiating cells have been shown to maintain their chromatin in 
an open, decondensed configuration relative to differentiated cells (reviewed in Gaspar-
Maia et al., 2011). Accordingly, chromatin decondensation appears to be a hallmark of cells 
engaged in switching fate, a process, which requires the acquisition of a stem cell-like state, 
which is essential for normal development. For example, during fertilization, 
decondensation of sperm chromatin is essential for the formation of the male pronucleus, 
which is necessary for successful fertilization (Longo & Anderson, 1968). Interestingly, 
sperm chromatin decondensation can be mimicked in Xenopus egg extracts and requires 
nucleoplasmin, an acidic, thermostable, abundant nuclear protein capable of binding histone 
proteins (Laskey et al., 1978; Philpott et al., 1991; Katagiri & Ohsumi, 1994). Similarly, 
Xenopus egg extracts can induce chromatin decondensation of heterologous somatic nuclei. 
It has been shown that nuclei derived from chicken erythrocytes incubated in Xenopus egg 
extract were induced to replicate their DNA, a process preceded by two sequential phases of 
chromatin decondensation (Blank et al., 1992). Chromatin decondensation was reported in 
cells of regenerating tissues of the tubeworm Owenia fusiformis 12 h after amputation (Fontes 
et al., 1980), a stage, which might correlate with cellular dedifferentiation whereby somatic 
cells at the amputation site withdraw from their differentiated state and acquire stem cell-
like state (Grafi, 2004). In plants, chromatin decondensation was found to be associated with 
cellular dedifferentiation induced following exposure to various stress conditions (e.g., 
protoplasting, exposure to dark) (Zhao et al., 2001; Tessadori et al., 2007; Damri et al., 2009, 
Grafi et al., 2011).  
The evidence that stem cells may assume a more open chromatin conformation is dated 
about 40 years ago with the description of the morphological characteristics of the so-called 
stem cells in the bone marrow by Murphy et al. (1971). Using electron microscopy 
examination of 3-day post hypoxic marrow, they found that the large mononuclear cells are 
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characterized by a fine nuclear chromatin (leptochromatic) with some peripheral 
condensation. Likewise, electron microscopy inspection of the erythropoietic cells of the 
chick showed that stem cells are characterized by large nuclei and homogenous 
euchromatin, while maturation is accompanied by an increase in nuclear condensation 
indicated by areas of heterochromatin (MacRae & Meetz, 1970). Also, ultrastructure of 
developing erythrocytes in the bone marrow of human adults showed that in the earliest 
stages, the nucleoplasm was chiefly composed of euchromatin, while during maturation 
heterochromatin was rapidly increased concomitantly with a reduction in nuclear size 
(Miura et al., 1974). Furthermore, using micrococcal nuclease, Weintraub (1978) showed that 
the nucleosome repeat length (NRL) increases from 190 to 212 basepairs during 
erythropoiesis in the chick, which was accompanied by a significant increase in the 
concentration of red cell specific histone H5, a linker histone necessary for stabilization of 
higher order chromatin structure (Robinson & Rhodes, 2006). This increase in NRL has 
recently been shown to be required for the formation of the 30 nm DNA fiber-induced 
chromatin compaction (Routh et al., 2008). Notably, similarly to animal stem cells, 
ultrastructural observations of the nuclei in the shoot apex (the plant stem cell niche) of the 
plant Tradescantia paludosa showed that a large proportion of the chromatin is organized as 
less condensed, diffused euchromatin fibrils (Booker & Dwivedi, 1973). 
It has been demonstrated that chromatin decondensation of somatic nuclei in Xenopus egg 
extracts requires the chromatin-remodeling nucleosomal adenosine triphosphatase (ATPase) 
ISWI (Kikyo et al., 2000). More recently, it has been shown that embryonic stem cells are 
extensively engaged in global gene transcription, due in part to overrepresentation of 
chromatin-remodeling genes and the general transcription machinery; this activity is 
diminished upon differentiation (Efroni et al., 2008). Knockdown by RNAi of the SWI/SNF 
remodeling factor BRG1 and of the ISWI-related chromodomain helicase DNA binding 
protein 1-like (Chd1l) resulted in impairment of ES cell differentiation and proliferation 
(Efroni et al., 2008). Indeed, knockdown of Chd1 in ES cells established its importance for 
maintaining open chromatin, pluripotency of embryonic stem cells, as well as for 
reprogramming of somatic cell to pluripotent state (Gaspar-Maia et al., 2009). Furthermore, 
reprogramming of somatic cells by the expression of the four transcription factors, Oct4, 
Sox2, Klf4 and c-Myc is facilitated by combined expression of chromatin remodeling 
components of the BAF (Brg1/Brahma-associated factor) complex (Singhal et al., 2010). 
2.4 Pattern of chromatin modifier gene expression in stem cells and dedifferentiating 
cells 
Open chromatin configuration emerges as a fundamental theme in pluripotent stem cell 
biology, and should be primarily served as a major attribute for defining the stem cell state. 
This open chromatin conformation is crucial for maintaining the stemness state, which 
might confer stem cells with the capacity for rapid switching into the appropriate 
transcriptional program upon induction of differentiation and with the flexibility needed for 
differentiation into multiple cell types. Thus, in looking for molecular features defining stem 
cells we should highlight the molecular components regulating chromatin structure, namely 
chromatin modifier genes (CMGs). There are two possible ways for maintaining the unique 
chromatin state characteristic of stem cells, which we define as quantitative and qualitative 
approaches. The quantitative approach suggests that the flexibility needed for stem cells to 
differentiate into multiple cell types can be achieved by promiscuous expression of CMGs, 
while the qualitative approach suggests that the open chromatin conformation characteristic 
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of stem cells is maintained by selective expression and repression of genes that promote the 
formation of permissive and restrictive chromatin, respectively.  
The quantitative approach gains support from analysis of the gene expression profiles of 
the plant shoot apical meristem (SAM) stem cells (Yadav et al., 2009). By introducing 
fluorescent reporters into SAM-enriched Arabidopsis background line, Yadav et al. (2009) 
have isolated by FACS three distinct cell types of the SAM stem cell niche and analyzed 
the transcriptome profiles of these cells. One major attribute of SAM stem cells appears to 
be a flexible chromatin state demonstrated by the overrepresentation of genes involved in 
chromatin organization (Yadav et al., 2009). Remarkably, further analysis of the available 
microarray dataset of the SAM stem cells revealed that among the 445 CMGs, which were 
represented on the ATH1 array, stem cells showed the expression of 297 genes whose 
expression signal is higher than 256 (>28). This unusual expression of chromatin modifier 
genes in SAM stem cells might confer the flexibility required for maintaining the 
pluripotent state of stem cells. 
Apparently, this widespread expression of CMGs observed in SAM stem cells is not 
mimicked in dedifferentiating plant cells. Transcriptome profiling of dedifferentiating 
protoplast cells (Damri et al., 2009) showed that among the 465 CMGs, which were 
represented on the ATH1 array only 95 genes displayed an expression signal higher than 
256 (>28). However, close examination of these CMGs highlighted the qualitative approach 
revealing that many of the genes that were down-regulated in dedifferentiating protoplasts, 
such as histone deacetylase encoding genes SRT2, HDA14 and HDT4, as well as linker 
histone genes Hon1 and Hon2 are implicated in chromatin compaction, while many of the 
CMGs that were up-regulated, such as histone acetyltransferase encoding genes HAF1, 
HAC5 and HAG3 as well as histone demethylase genes JMJ21 and JMJ13 are implicated in 
chromatin decondensation. Thus the expression profile of CMGs favors the acquisition of an 
open chromatin conformation in dedifferentiating cells.  
Since open chromatin configuration characterizes stem cells as well as dedifferentiated cells 
in plants and animals, the study of these cells in plants might have bearing to understanding 
inherent biological features of animal stem cells. 
2.5 CMGs as a tool for monitoring pluripotency 
We hypothesized that these features of quantitative and qualitative CMG expression of 
SAM stem cells and dedifferentiating cells, respectively, might hold also for human stem 
cells and dedifferentiating cells and could serve as a distinguishing feature between animal 
cells displaying various levels of pluripotency. To assess the qualitative approach, we first 
predefined a set of human CMG families, which were selected based on their predicted 
chromatin function, namely, histone deacetylases (HDACs) involved in heterochromatin 
formation, histone acetyltransferases (HATs), which are involved in euchromatin formation 
and the jumonji family of histone demethylases implicated in both euchromatin and 
heterochromatin formation. We then checked the expression level of these predefined CMGs 
(listed in Table 1) in a recently published meta-analysis of human gene expression datasets 
(Lukk et al., 2010). In this study, the authors collected and integrated high-quality data from 
5,372 samples from 206 different studies, all generated using Affymetrix U133A arrays and 
deposited in public databases. Using text mining and curation, the authors binned the 
samples in 369 biological groups, each representing a particular cell or tissue type, disease 
state or cell line. Additionally, samples were grouped more crudely according to different 
criteria, one of which divided the samples into four meta-groups: Cell lines, Neoplasms, 
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Non-neoplastic diseases, and Normal. We have downloaded the entire gene expression 
matrix from the ArrayExpress repository (accession number E-MTAB-62), and reduced it to 
include only the 1033 samples of the "Normal" meta-group, and the 40 CMGs indicated in 
Table 1. Subsequently, probe sets which represented the same gene were consolidated as 
follows: (1) probe sets with signal intensity lower than 5 (in log2 scale) in all 1033 samples 
were removed, provided that at least one probe set for the same gene had signal intensity 
higher than 5 (in log2 scale) in at least one of the samples. (2) The signal intensities of the 
remaining probe sets were averaged to yield a single expression value per gene per sample. 
The resulting matrix was loaded into Partek Genomics SuiteTM. To allow for gene-wise 
comparison of expression profiles, expression values were standardized such that the mean 
and standard deviation of each gene's values were 0 and 1, respectively. The standardized 
dataset was subjected to bi-directional hierarchical clustering using Euclidean distance and 
complete linkage. Finally, sample annotations indicating 6 meta-groups (brain, cell line, 
hematopoietic system, incompletely differentiated, muscle, solid tissue) and operating 
laboratory were added. As shown in Fig. 1, based on their expression pattern, the CMGs 
were clearly clustered into three major clades. Most intriguing is clade 1 displaying  
 
 
Fig. 1. Bi-directional hierarchical clustering of 40 CMGs expression in 1033 normal human 
tissues derived from public datasets compiled by Lukk et al. (2010). Gene-wise standardized 
expression level is shown as colored squares on a red-black-green scale (from up- to down-
regulation, respectively). Samples are labeled by two color columns indicating their meta-
group and operating laboratory. The three clustered CMG groups (1-3) displaying peculiar 
upregulation in a specific sample clade (A, B, D) are boxed yellow.  
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upregulation of 18 CMGs out of the 40 examined as they form a homogenous cluster of 
samples (clade A in Fig. 1) derived almost entirely from the hematopoietic system reported 
by various labs. Notably, 14 out of the 18 CMGs in clade 1 are implicated in euchromatin 
formation and gene activation (Table 1). Interestingly, 10 out of the 14 CMGs belong to the 
jumonji protein family of histone demethylases, most of which (8 genes) are implicated in 
removal of repressive methyl group and formation of euchromatin (Table 1). In clade 2, 9 
CMGs are upregulated, most of which are implicated in heterochromatin formation (Table 
1). This group defines a cluster (clade D in Fig. 1) composed of samples derived from the 
hematopoietic system (mostly differentiated lymphocytes, macrophages and granulocytes), 
cell line, solid tissue and incompletely differentiated cells. Clade 3 is characterized by the 
expression of 13 CMGs distributed almost equally between genes implicated in eu- and 
heterochromatin and defines a cluster (clade B in Fig. 1) composed of diverse samples 
derived mostly from the brain but also from hematopoietic system, muscle and solid tissue. 
Based on this analysis and the capacity for open chromatin configuration (Table 1) we 
predict that clade A represents a group of cells most of which from the hematopoietic 
system with the highest pluripotency level, clade B has moderate and clade D has the lowest 
pluripotency level. Clade C generates a cluster of cells derived from the brain, solid tissue 
and muscle with no clear clustering of the CMGs. 
To evaluate the strength of our prediction we analyzed the expression pattern of the 
predefined CMGs in a microarray dataset (GSE18290) obtained for early stages of human 
embryos, which include one-, two-, four-, and eight-cell stage embryos, morula stage and 
the blastocyst stage (Xie et al., 2010). The raw CEL files of the respective Affymetrix Human 
Genome U133 Plus 2.0 Arrays were downloaded from NCBI GEO and further preprocessed 
using RMA in Partek Genomics SuiteTM. Expression values of 38 out of the 40 predefined 
CMGs were standardized and subjected to gene wise hierarchical clustering using Euclidean 
distance and complete linkage. The resulting heat map shown in Fig. 2 revealed a sharp 
transition in the expression of CMGs between four- and eight-cell embryos, which might 
reflect transition from high pluripotency level (totipotency) to a more reduced one. The 
finding that blastomers derived from two- and four-cell embryos retain totipotency (Van de 
Velde et al., 2008) may support this notion. The abrupt transition in pattern of CMG 
expression is consistent with the largest changes in transcriptome profile observed between 
four- and eight-cell stages of human embryos (Xie et al., 2010) as well as with the timing of 
zygote genome activation (ZGA) in humans, which commences between the four- and eight-
cell stages of embryo development concomitantly with the degradation of maternal 
transcripts (Braude et al., 1988; Nothias et al., 1995). Based on the expression pattern of 
CMGs, cell samples could be divided into two major groups, namely group A, which is 
composed of one-to four-cell embryos displaying 18 (probably maternal) CMGs (clade 2), 
most of which (12 out of 18) are implicated in euchromatin formation and gene 
transcription. Group B is composed of eight-cell embryos, morula and blastocyst displaying 
upregulation of 20 CMGs (probably zygotic transcripts, clade 1) distributed equally between 
CMGs implicated in eu- and heterochromatin formation. Based on this analysis, it appears 
that overrepresentation of CMGs whose products are associated with open chromatin and 
gene transcription characterizes cells with high pluripotency level and thus supporting our 
hypothesis. We suggest that this attribute may faithfully serve as a tool for assessing the 
pluripotency level of the cell. 
www.intechopen.com
 Embryonic Stem Cells – Basic Biology to Bioengineering  
 
272 
Gene name Gene function Predicted 
chromatin 
function 
Group 
A/1 
 
Group 
B/3 
 
Group 
D/2 
 
HDAC4 Histone deacetylase Hetero + - - 
UBE2B H2B ubiquitination Eu + - - 
HDAC9 Histone deacetylase Hetero + - - 
MYST3 HAT Eu + - - 
KDM2A H3K36 demethylase Hetero + - - 
KDM6B H3K27 demethylase Eu + - - 
UTY H3K27 demethylase Eu + - - 
KDM3A H3K9 demethylase Eu + - - 
JMJD1C H3K9 demethylase Eu + - - 
CREBBP HAT Eu + - - 
EP300 HAT Eu + - - 
HSPBAP1 Jumonji protein unknown + - - 
JHDM1D H3K9/K27 demethyl. Eu + - - 
MYST1 HAT Eu + - - 
PHF2 H3K9 demethylase Eu + - - 
KAT2B HAT Eu + - - 
KDM3B H3K9 demethylase Eu + - - 
PHF8 H3K9/K27 demethyl. Eu + - - 
KDM5B H3K4 demethylase Hetero - - + 
HDAC1 Histone deacetylase Hetero - - + 
HDAC3 Histone deacetylase Hetero - - + 
UBE2A H2B ubiquitination Eu - - + 
HAT1 Cytoplasmic HAT unknown - - + 
HDAC2 Histone deacetylase Hetero - - + 
HIF1AN Jmj protein Hetero? - - + 
KDM1 H3K4 demethylase Hetero - - + 
ELP3 HAT Eu - - + 
HDAC6 Histone deacetylase Hetero - + - 
KDM5C H3K4 demethylase Hetero - + - 
HR Jumonji protein unknown - + - 
HDAC11 Histone deacetylase Hetero - + - 
MYST2 HAT Eu - + - 
KAT2A HAT Eu - + - 
MYST4 HAT Eu - + - 
TAF1 HAT Eu - + - 
JMJD4 unknown unknown - + - 
HDAC7 Histone deacetylase Hetero - + - 
KDM8 H3K36  demethylase Hetero - + - 
KAT5 HAT Eu - + - 
HDAC5 Histone deacetylase Hetero - + - 
Table 1. Summary of the expression pattern of CMGs in the different clustered groups 
(shown in Fig. 1) and their predicted chromatin function. Eu, Euchromatin, HAT, histone 
acetyltransferase; Hetero, heterochromatin 
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Fig. 2. Clustering of 38 CMGs expression in human embryos at various developmental 
stages derived from public datasets compiled by Xie et al. (2010, GSE18290). Gene-wise 
standardized expression level is shown as colored squares on a red-black-green scale (from 
up- to down-regulation, respectively). The two clustered CMG groups (upper dendrogram) 
displaying peculiar upregulation in a specific sample group (A and B) are boxed yellow. 
CMGs highlighted green and red are predicted to be involved in formation of euchromatin 
and heterochromatin, respectively. 
3. Hazardous pathways associated with cellular dedifferentiation (iPS cells) 
and with culturing stem cells 
It is now quite accepted that reprogramming of somatic cells in culture as well as culturing 
of stem cells are prone to hazardous genomic modifications and thus undermine their 
potential use in regenerative medicine. The complexity of hES cells is highlighted by the fact 
that injection of these cells (in their un-transformed state) into immunodeficient mice 
induced teratoma formation - a practice commonly used as a stringent assay to prove their 
existence. Indeed, animal embryonic stem cells often displayed genomic abnormalities in 
culture, which frequently resulted in malignant transformation (Lefort et al. 2009; Ben David 
& Benvenisty, 2011). Similarly, human iPS cells (Takahashi & Yamanaka, 2006), like human 
ES cells can acquire genetic abnormalities in the culture (Mayshar et al. 2010). These genetic 
aberrations are presumed to arise in part from culture adaptation while others are suspected 
to originate from the parent somatic cell. The later may be overcome by derivation of 
somatic cells from embryonic tissue (Ben-David et al., 2010). Yet, derivation of somatic cells 
from embryos, such as mouse embryonic fibroblasts (MEFs) did not improve significantly 
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reprogramming efficiency or reduced genetic and epigenetic abnormalities (Marión et al., 
2009). Cell type of origin has a major effect on the properties of mouse iPS cells at early-
passages, where iPS cells retain a transient epigenetic memory of their somatic cells of origin 
demonstrated by their differential gene expression and differentiation capacity, while at late 
passages these differences were attenuated (Polo et al., 2010). 
Reprogramming of somatic cells to generate iPS cells is believed to commence with the 
introduction of the so-called ‘pluripotent genes’ into cultured somatic cells. Commonly, 
researchers are not aware that reprogramming has already initiated in somatic cells when they 
are removed from the soma and placed in tissue culture environments. Cell culturing of 
primary cells might impose an extreme stress over the cells resulting in reprogramming, 
dedifferentiation and acquisition of pluripotency prior to reentry of somatic cells [e.g., mouse 
embryonic fibroblasts (MEFs)] to the cell cycle (Fig. 3) – a stage, which is often overlooked. 
This aspect of cell culturing has been highlighted by Barbra McClintock (1984) in her Nobel 
article ‘The significance of responses of the genome to challenge’. McClintock (1984) has 
recognized the potential for hazardous genetic variation that can be induced following 
exposure of cells to stress (e.g., cell culturing, virus infection) stating “Some responses to stress 
are especially significant for illustrating how a genome may modify itself when confronted 
with unfamiliar conditions. Changes induced in genomes when cells are removed from their 
normal locations and placed in tissue culture surroundings are outstanding examples of this. 
The establishment of a successful tissue culture from animal cells, such as those of rat or 
mouse, is accompanied by readily observed genomic restructuring.” McClintock predicted 
that these aberrant genome responses to stress are likely to be induced by mobilization of 
transposable elements. Therefore, we should consider the possibility that the genotype(s) of 
somatic cells entering the cell cycle may not be identical to the genotype of the original somatic 
cells; a genotype(s) conferring increasing fitness for tissue culture conditions may prevail. 
 
 
Fig. 3. Reprogramming of somatic cells. The removal of somatic cells from the body is 
stressful and might induce dedifferentiation (reprogramming) and acquisition of stem cell-
like state prior to reentry into the cell cycle (G1-S transition). Note that due to genetic 
variation induced during dedifferentiation the genotype of cells entering the cell cycle may 
be different from the genotype of the original somatic cells.  
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In animals, somatic cell nuclear transfer (SCNT) as well as iPSCs, both are dedifferentiation-
driven processes appear to be very limited (Tamada & Kikyo, 2004; William & Plath, 2008). 
This is probably due, at least in part, to a high frequency of p53-mediated DNA damage 
response and p53-dependent apoptosis, which are acting to ensure genomic integrity 
(Marión et al., 2009). Although, it is presumed that failure in reprogramming is selective for 
those cells with preexisting DNA damage, it cannot be excluded that DNA damage or 
‘irreversible genomic modifications’ are induced in cells (e.g., protoplasts, primary MEFs) in 
the course of stress-induced cellular dedifferentiation (Fig. 3) or cell culturing via DNA 
recombination and DNA transposition (Pouteau et al., 1991; Hirochika, 1993; Grafi et al., 
2007; Grafi, 2009; Grafi et al., 2011). Almost half of the human genome is composed of 
transposable elements, some of which still retain their capacity for transposition into genes, 
which could lead to genetic instability and human diseases (reviewed in Belancio et al. 
2009). Indeed, Alu and Line-1 expression and retrotransposition have been reported in 
human ES cells and in human neural progenitor cells (Garcia-Perez et al., 2007; Coufal et al., 
2009; Macia et al., 2011). Notably, some of these retroelements are often activated in various 
cell lines following exposure to stress (reviewed in Oliver & Greene, 2009).  
Presently, it is not clear why the genome become vulnerable under certain stress conditions. 
One possibility is that following exposure to stress the genome is reacting by extensive and 
stochastic reorganization culminating in global chromatin decondensation and acquisition 
of dedifferentiated, stem cell-like state (reviewed in Grafi, 2009). Stochastic epigenetic 
modifications may release constraints over transposable elements resulting in their 
activation and transposition into other chromosomal sites. Stress-induced decrease in 
methylation of repetitive elements [long interspersed nucleotide element (LINE)-1 and Alu 
repetitive elements] was reported in blood samples derived from elderly individuals 
following exposure to traffic particles (Baccarelli et al., 2009). A whole-genome profiles of 
DNA methylation of several human iPS cell lines, showed aberrant reprogramming of DNA 
methylation; regions proximal to centromeres and telomeres display incomplete 
reprogramming of non-CG methylation, and differences in CG methylation and histone 
modifications (Lister et al., 2011).  
4. Discussion 
The capacity of somatic cells to dedifferentiate and acquire stem cell-like state is an 
important goal toward developing an efficient tool for use in regenerative medicine. Yet, the 
process of dedifferentiation is complex and unsafe resulting from increased incidents of 
DNA transposition/recombination-induced genetic variation and genome instability (Grafi, 
2009). In addition, the findings that both embryonic stem cells (ESCs) and iPS cells show 
higher frequencies for genetic abnormalities relative to other cell lines limit their suitability 
for clinical use in regenerative medicine (Mayshar et al., 2010; Laurent et al., 2011). The 
generation of iPS cells from somatic cells by various means emerged as one reasonable 
approach for generating autologous iPS cells for clinical applications. This methodology 
solves the problem of transplant rejection and also moral concerns often raised regarding 
the use of ES cells. However, the process of generating iPS cells is very inefficient, has very 
low rate of success and may be subjected to hazardous genetic variation (Grafi, 2009) 
leading, at least partly, to p53-dependent cell death (Marión et al., 2009). The limited success 
in iPS cells is enigmatic inasmuch as dedifferentiation is an integral process of development 
both in plants and animals. It underlies the regenerative capacity of certain vertebrates 
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(Brockes & Kumar, 2008) as well as of plants (reviewed in Grafi, 2004) and, at least partly, 
the capacity for transdifferentiation, that is, the conversion of one cell type to another (Tosh 
& Slack, 2002).  
We should consider the fact that the capacity for switching cell fate in animals suggests that 
the machinery needed for this transition is already exist in the framework of the cell 
including the pluripotent genes (e.g., OCT4, SOX2) whose ectopic expression in cultured 
cells may induce formation of pluripotent stem cells. Hence, why introducing these genes 
exogenously instead of activating the endogenous ones? Accumulating data suggest that 
reprogramming does not require the ‘four factors’ (OCT4, SOX2, KLF4, c-Myc) and can be 
carried out with only one factor OCT4 (Kim et al., 2009). This raises the question whether 
reprogramming is achieved due to ectopic expression of pluripotent genes or due to 
endogenous ones being activated as a consequence of the procedure itself (viral 
transduction), namely, virus-induced chromatin reorganization (Monier et al., 2000). Indeed, 
induction of pluripotency does not necessarily require exogenous factors and can be carried 
out by extracts derived from stem cells or undifferentiated human NCCIT carcinoma cells 
(Taranger et al., 2005). More recently it has been shown that pretreatment of somatic cells 
with chromatin modulators, namely, DNA methyltransferase and histone deacetylase 
inhibitors can improve reprogramming and the formation of hESC-like colonies by 
embryonic stem cell extracts (Han et al., 2010). Chromatin architecture is a fundamental 
theme in pluripotency and as such should be the primary means for activation of silent 
genes whose products involved in establishing of the pluripotent state. Support to this view 
are the open chromatin configuration characteristic of stem cells and the finding that 
chromatin remodeling factors play a critical role in maintaining open chromatin and 
reprogramming of somatic cells to pluripotent state (Efroni et al., 2008; Gaspar-Maia et al., 
2009). Accordingly, it has recently been shown that chromatin-remodeling components of 
the BAF complex facilitate the reprogramming of somatic cells into pluripotent state 
(Singhal et al., 2010).  
5. Conclusions 
The use of CMGs for reprogramming of somatic cells has not been exploited sufficiently. We 
should consider manipulating of the activities of chromatin modifiers capable of facilitating 
the formation of open chromatin conformation. Emphasis should be given to those genes 
whose products actively remove repressive marks from histone tails, such as histone 
demethylases (Table 1), as a necessary step toward opening of otherwise closed chromatin. 
In this respect, together with existing tools such as the PluriTest (Muller et al., 2011), our 
bioinformatic data suggest that the transcription profile of CMGs can be formulated into a 
robust bioinformatic tool for assessing the pluripotency level of cells.  
Obviously, the removal of cells (e.g., stem cells, somatic cells) from their normal location in 
the body and placing them under tissue culture conditions is hazardous and should be 
avoided, unless we find the way(s) to control the extent of genetic variation induced during 
dedifferentiation and cell culturing. An alternative approach has been suggested by 
Abramovich et al. (2008) in their article entitled ‘Have we reached the point for in vivo 
rejuvenation?’ The authors suggested to try and imitate natural rejuvenation processes and 
to test the possibility of inducing dedifferentiation and the pluripotent state in somatic cells 
in vivo. Future challenges will be to gain knowledge and find the appropriate means for 
inducing dedifferentiation at specific tissue or organ in vivo for efficient and safe 
regenerative medicine. 
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